Scinovex
review Open AccessTop 1% cited

Benzodiazepines I: Upping the Care on Downers: The Evidence of Risks, Benefits and Alternatives

Journal of Clinical Medicine · 2018 · Vol. 7(2) · pp. 17–17
Jeffrey GuinaBrian Merrill

Abstract

Benzodiazepines are some of the most commonly prescribed medications in the world. These sedative-hypnotics can provide rapid relief for symptoms like anxiety and insomnia, but are also linked to a variety of adverse effects (whether used long-term, short-term, or as needed). Many patients take benzodiazepines long-term without ever receiving evidence-based first-line treatments (e.g., psychotherapy, relaxation techniques, sleep hygiene education, serotonergic agents). This review discusses the risks and benefits of, and alternatives to benzodiazepines. We discuss evidence-based indications and contraindications, and the theoretical biopsychosocial bases for effectiveness, ineffectiveness and harm. Potential adverse effects and drug-drug interactions are summarized. Finally, both fast-acting/acute and delayed-action/chronic alternative treatments for anxiety and/or insomnia are discussed. Response to treatment-whether benzodiazepines, other pharmacological agents, or psychotherapy-should be determined based on functional recovery and not merely sedation.

Citations
247
FWCI
23.54
field-weighted impact
References
111
Percentile
100%
vs. same field & year
Citations per year
References
Opioid-induced Hyperalgesia
Anesthesiology · 2006 · 1,162 citations
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.

Benzodiazepines I: Upping the Care on Downers: The Evidence of Risks, Benefits and Alternatives · Scinovex